Funded by
the European Union

Bringing biomedical discoveries closer to investment

TransBioNet connects researchers, start-ups and innovation support organisations across Europe to help promising drug discovery projects move towards investment readiness. Through shared assessment tools, training and access to specialist expertise and research infrastructure, we help teams identify their next steps and prepare for further development.

Three researchers in a laboratory discussing a molecular model on a screen
Total project budget
€1.96M
Partners in the consortium
7
Countries involved
6
Months of the project
36
Three researchers discussing a sample at a laboratory microscope

Support for early-stage drug discovery

Promising research needs a clear development pathway. TransBioNet helps research teams and innovation support organisations identify what a project needs to progress, access relevant expertise and prepare for further development and investment.

More about the project

How we support innovation

  • Project assessment

    Shared tools to support more standardised evaluations of early-stage drug discovery projects.

  • Research infrastructure

    An atlas mapping research infrastructures and services relevant to biomedical translation across Europe.

  • Skills and collaboration

    Training, peer learning and cross-border secondments to strengthen skills and knowledge exchange among intermediaries.

  • Open calls

    Mentoring and bootcamps for selected projects, with validation funding planned for the highest-ranked.

News

Partners

7 organisations from 6 countries work together in the consortium.

Let’s talk about TransBioNet

Have a question about the project, future open calls or opportunities to collaborate? Get in touch with our team using the form.